Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Solitary Fibrous Tumors | 1 | 2022 | 48 | 0.760 |
Why?
|
| Fat Necrosis | 1 | 2020 | 60 | 0.670 |
Why?
|
| Subcutaneous Fat | 1 | 2020 | 65 | 0.670 |
Why?
|
| Abdominal Neoplasms | 1 | 2021 | 251 | 0.660 |
Why?
|
| Machine Learning | 1 | 2021 | 365 | 0.610 |
Why?
|
| Diagnostic Imaging | 4 | 2021 | 1174 | 0.590 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 586 | 0.590 |
Why?
|
| Prostate | 1 | 2022 | 1090 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2019 | 7787 | 0.540 |
Why?
|
| Pancreas | 3 | 2015 | 737 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 7912 | 0.500 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 380 | 0.500 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 1260 | 0.480 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2010 | 10 | 0.370 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 79 | 0.370 |
Why?
|
| Pelvic Pain | 1 | 2010 | 49 | 0.360 |
Why?
|
| Cross Infection | 1 | 2015 | 547 | 0.350 |
Why?
|
| Endometriosis | 1 | 2010 | 232 | 0.290 |
Why?
|
| Leiomyosarcoma | 2 | 2021 | 253 | 0.290 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2019 | 1903 | 0.290 |
Why?
|
| Laparoscopy | 1 | 2015 | 1302 | 0.250 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1385 | 0.240 |
Why?
|
| Diagnosis, Differential | 5 | 2022 | 4838 | 0.230 |
Why?
|
| Abdomen | 2 | 2021 | 346 | 0.210 |
Why?
|
| Neoplasms, Second Primary | 2 | 2021 | 1388 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 3 | 2015 | 5257 | 0.200 |
Why?
|
| Seminal Vesicles | 1 | 2022 | 149 | 0.190 |
Why?
|
| Anilides | 1 | 2024 | 295 | 0.190 |
Why?
|
| Neoplasms | 4 | 2021 | 15931 | 0.190 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2024 | 191 | 0.190 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2024 | 242 | 0.190 |
Why?
|
| Abdomen, Acute | 1 | 2020 | 38 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2015 | 5673 | 0.170 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 5318 | 0.170 |
Why?
|
| Renal Veins | 1 | 2019 | 63 | 0.160 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2021 | 402 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 193 | 0.150 |
Why?
|
| Humans | 24 | 2024 | 270601 | 0.140 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 336 | 0.140 |
Why?
|
| Pyridines | 1 | 2024 | 1313 | 0.140 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2020 | 881 | 0.140 |
Why?
|
| Liposarcoma | 1 | 2017 | 248 | 0.120 |
Why?
|
| Peritoneal Cavity | 1 | 2015 | 58 | 0.120 |
Why?
|
| Subcutaneous Tissue | 1 | 2015 | 57 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 376 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 930 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2019 | 599 | 0.110 |
Why?
|
| Female | 12 | 2024 | 148790 | 0.110 |
Why?
|
| Observer Variation | 1 | 2015 | 709 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2015 | 193 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2019 | 1931 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 10402 | 0.100 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2013 | 182 | 0.090 |
Why?
|
| Middle Aged | 7 | 2024 | 90450 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2011 | 112 | 0.090 |
Why?
|
| Sarcoma | 1 | 2021 | 1851 | 0.090 |
Why?
|
| Iron Overload | 1 | 2010 | 33 | 0.090 |
Why?
|
| Male | 10 | 2024 | 128395 | 0.080 |
Why?
|
| Skin | 1 | 2015 | 1281 | 0.080 |
Why?
|
| Liver | 1 | 2019 | 3056 | 0.080 |
Why?
|
| Pancreatic Cyst | 1 | 2010 | 111 | 0.080 |
Why?
|
| Ligaments | 1 | 2009 | 42 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 324 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2017 | 4837 | 0.080 |
Why?
|
| Pancreatic Diseases | 1 | 2009 | 113 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2009 | 144 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 14021 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2010 | 690 | 0.070 |
Why?
|
| Endosonography | 1 | 2010 | 551 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2189 | 0.070 |
Why?
|
| Adult | 6 | 2024 | 81960 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 629 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 2394 | 0.060 |
Why?
|
| Pancreatectomy | 1 | 2010 | 690 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2017 | 39922 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2019 | 17075 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6193 | 0.060 |
Why?
|
| Contrast Media | 1 | 2011 | 1505 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 4053 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 4899 | 0.050 |
Why?
|
| Adolescent | 3 | 2019 | 32684 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 10713 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5597 | 0.050 |
Why?
|
| Aged | 5 | 2024 | 73534 | 0.050 |
Why?
|
| Young Adult | 3 | 2017 | 22219 | 0.050 |
Why?
|
| Periaqueductal Gray | 1 | 2000 | 13 | 0.050 |
Why?
|
| Superior Colliculi | 1 | 2000 | 16 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2017 | 1581 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2000 | 214 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2010 | 1830 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 224 | 0.040 |
Why?
|
| Fear | 1 | 2000 | 259 | 0.040 |
Why?
|
| Aggression | 1 | 2000 | 250 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 3707 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2020 | 377 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2019 | 245 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2019 | 283 | 0.040 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 1 | 2017 | 165 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 2903 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 16719 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 551 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2020 | 1464 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 7046 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2017 | 1013 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 2199 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 4006 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2024 | 13413 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 5099 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 22520 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 4964 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7914 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10267 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12527 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 5238 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 1061 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 3048 | 0.010 |
Why?
|
| Arousal | 1 | 2000 | 128 | 0.010 |
Why?
|
| Texas | 1 | 2010 | 6445 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 455 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 598 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 2811 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2000 | 624 | 0.010 |
Why?
|
| Motor Activity | 1 | 2000 | 711 | 0.010 |
Why?
|
| Child | 1 | 2017 | 30558 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 15270 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 6397 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 31084 | 0.010 |
Why?
|
| Animals | 1 | 2000 | 61346 | 0.000 |
Why?
|